Evolvements on diagnosis and interventional therapy of glioblastoma

MRI and ultrasound technique have improved the diagnosis of glioblastoma and increased clinical value for themselves. Superselective intravascular perfusion chemotherapy/radiotherapy bring less damage, more local effectiveness and less adverse reactions, presenting bright future with involvement of anti-angiogenesis. Mechanisms of drug effect and recurrence of glioblastoma should be put in more emphasis for research work. Reducing diagnostic cost, promoting veracity and reliability of new techniques and intensifying the combination of Superselective intravascular perfusion and chemotherapeutic drugs will provide important significance for researches in the near future. (authors)